| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022382 |
| Receipt No. | R000025795 |
| Official scientific title of the study | Experiment for verification of the anti-fatigue effects of hydrogen-rich water in daily life: cross-over study. |
| Date of disclosure of the study information | 2016/05/20 |
| Last modified on | 2016/08/10 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Experiment for verification of the anti-fatigue effects of hydrogen-rich water in daily life: cross-over study. | |
| Title of the study (Brief title) | The anti-fatigue effects of hydrogen-rich water. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Investigation of the anti-fatigue effects of hydrogen-rich water on subjective fatigue and autonomic nervous system in daily life. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes in subjective fatigue, autonomic nervous function,
oxidation stress and antioxidant activity after 4 weeks. |
| Key secondary outcomes | Amount of activity
Cognitive function |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of test water for 4 weeks. / Wash out for 4
weeks. / Ingestion of placebo water for 4 weeks. |
|
| Interventions/Control_2 | Ingestion of placebo water for 4 weeks. / Wash out for 4
weeks. / Ingestion of test water for 4 weeks. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Healthy persons who are aged from 20 to 49 years.
2.Persons who are not shift worker. |
|||
| Key exclusion criteria | 1.Pregnant women.
2.Persons who are in treatment. 3.Persons who have medical history of cardiovascular disease. 4.Persons who have medical history of nervous system disease such as unconsciousness, coma, and convulsion, etc. 5.Persons who have insomnia. 6.Persons who have food allergy. 7.Persons who are heavy user of alcohol. 8.Persons who are judged not suitable to participate in this trial by investigators. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuyoshi Watanabe |
| Organization | Osaka City University |
| Division name | Center for Health Science Innovation |
| Address | 9F, Tower-C, Knowledge Capital, Grand Front Osaka, 3-1 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan. |
| TEL | 06-6485-0288 |
| chsi-b@ado.osaka-cu.ac.jp | |
| Public contact | |
| Name of contact person | Kei Mizuno |
| Organization | Osaka City University |
| Division name | Center for Health Science Innovation |
| Address | 9F, Tower-C, Knowledge Capital, Grand Front Osaka, 3-1 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan. |
| TEL | 06-6485-0288 |
| Homepage URL | |
| chsi-b@ado.osaka-cu.ac.jp | |
| Sponsor | |
| Institute | Osaka City University Center for Health Science Innovation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Melodian Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪市立大学健康科学イノベーションセンター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025795 |